Amytrx Therapeutics, Inc. — Form D
Amytrx Therapeutics, Inc. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-31. The offering totals $6.0M, of which $725K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-01-31
- Form: D
- Accession: 0001649024-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $725K
- Remaining: $5.3M
- Minimum investment: $50K
- Investors: 7
- Date of first sale: 2023-12-15
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-504045
Issuer
- Name: Amytrx Therapeutics, Inc.
- CIK: 0001649024
- Entity type: Corporation
- Jurisdiction: TENNESSEE
- Incorporated: 2017
- Address: 40 Burton Hills Boulevard, NASHVILLE, TN, 37215
- Phone: 205-427-8787
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Dennis Carlo | Director | La Jolla, CA |
| Matthew Gonda | Director | Nashville, TN |
| Lawrence Greer | Director | Nashville, TN |
| Michael Howell | Director | Henderson, NV |
| Satish Joshi | Director | Nashville, TN |
| Raymond Pirtle | Director | Nashville, TN |
| Matthew Gonda | Executive Officer | Nashville, TN |
| Daniel Pirtle | Director | NASHVILLE, TN |
| Thomas Andrews | Director | NASHVILLE, TN |
| Daniel Canale | Director | NASHVILLE, TN |
| Larry Greer | Director | NASHVILLE, TN |
| Dennis J Carlo | Director | SAN DIEGO, CA |
| Lawrence W Greer | Director | Birmingham, AL |
| Raymond J Pirtle | Director | Nashville, TN |
| Matthew A Gonda | Director | Nashville, TN |
| Matthew A Gonda | Executive Officer | Nashville, TN |
| Thomas G Andrews | Director | Nashville, TN |
| Raymond M Pirtle | Director | Nashville, TN |
| Jerry M Kluft | Director | Nashville, TN |
| Lawrence G Greer | Director | Nashville, TN |
| Robert E McNeilly | Director | Nashville, TN |
| Jack J Hawiger | Director | Nashville, TN |
Other filings by this issuer (5)
More